Jump Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,309
Closed -$475K 1886
2025
Q4
$475K Sell
42,309
-125,247
-75% -$1.43M 0.01% 1340
2025
Q3
$1.94M Buy
167,556
+110,713
+195% +$1.3M 0.02% 746
2025
Q2
$696K Buy
+56,843
New +$715K 0.01% 1111
2022
Q4
Sell
-33,800
Closed -$736K 1564
2022
Q3
$736K Buy
33,800
+8,500
+34% +$222K 0.03% 742
2022
Q2
$691K Sell
25,300
-15,900
-39% -$457K 0.03% 715
2022
Q1
$1.38M Buy
41,200
+1,070
+3% +$34.5K 0.06% 405
2021
Q4
$1.39M Buy
40,130
+7,049
+21% +$228K 0.09% 283
2021
Q3
$1.03M Buy
+33,081
New +$1.12M 0.07% 284

Other funds holding AVNS

Jump Financial's AVNS Position: Q1 2026 in Review

Jump Financial sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 42,309 shares — an estimated $475K sold.

Jump Financial first reported a position in AVNS in Q3 2021 and held it in 8 quarters. The position peaked at $1.94M in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Jump Financial reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 42,309 Avanos Medical shares in Q1 2026, an estimated $475K.
  • Jump Financial first reported a position in Avanos Medical in Q3 2021 and held it in 8 quarters.
  • Jump Financial's Avanos Medical position peaked at $1.94M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.